The Federal Circuit upheld a ruling that Moderna's COVID-19 vaccine does not infringe Alnylam's mRNA patents related to the SM-102 lipid used in Spikevax.

SK bioscience won a patent case against Moderna in Korea, impacting mRNA technology development and potential vaccine exports to developing countries.

Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators are restricting access to immunizations under the leadership of Health ...

Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in their COVID-19 vaccine, asking a Delaware federal court on Tuesday to ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing Covid shot does not currently face.

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

Moderna Inc. has agreed to do a placebo-controlled trial of its new Covid vaccine that was recently approved by US regulators, Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday.

Here are the five key takeaways from the announcement: 1. mNexspike is a lower-dose next-generation vaccine Moderna says the new formula uses only one-fifth of the dose in its current COVID-19 shot.

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination COVID and flu shot for people 50 and over, a setback for the company.

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the results of a phase 3 clinical trial published Wednesday in the Journal of ...

SK bioscience filed a nullity suit in 2023 challenging Moderna's patent on modified nucleosides, nucleotides and nucleic acids, as well as their uses, the company said in a press release.